Disclosures: Patrick INGILIZ: GILEAD: Speaking and Teaching, Abbvie: Speaking and Teaching, ViiV: Speaking and Teaching, Erwan Vo Quang: Nothing to Disclose, Maud Lemoine: Nothing to Disclose, Amie Ceesay: Nothing to Disclose, Gibril Ndow: Nothing to Disclose, Marie-Noelle Hilleret: Nothing to Disclose, Laure Bordy: Nothing to Disclose, Thomas Decaens: Nothing to Disclose, Anne-Laure Mazialivoua: Nothing to Disclose, Yusuke Shimakava: Nothing to Disclose, Alhagie Bakoteh: Nothing to Disclose, Jean-Michel Pawlotsky: Abbvie: Speaker, Abbott: Advisor, Gilead: Speaking and Teaching, GSK: Advisor, Isabelle CHEMIN: Nothing to Disclose, Stphane Chevaliez: Nothing to Disclose, Vincent Leroy: Nothing to Disclose 448 HEPATIC STEATOSIS IS ASSOCIATED WITH HBSAG CLEARANCE IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION Emin Bodakci 1 Saba Kiremiti 1 Serkan Duman 1 Zeynep Melekoglu Ellik 1 Mesut Gumussoy 1 Sevinc Tue Guvenir 1 Volkan YILMAZ 1 ramazan erdem er 1 Fatih Karakaya 1 Hale Gokcan 1 Atilla Elhan 1 Berna Savas 1 Ramazan Idilman 1 , 1 Ankara University Background: The present study aimed to determine the effect of hepatic steatosis detected by liver biopsy on HBsAg seroclearance and disease outcome in hepatitis B virus (HBV)-infected patients
Effects of GLP1-RA on potential kidney outcomes are currently being explored
The visual impact is dramatic because people see your face and neck in every interaction
However, GLP-1 receptors are also present in skeletal muscle tissue, where the medication can influence cellular ion balance and electrolyte handling
Exercise, resistance training, and practical tools What type of exercise is most important for women in midlife
